Pain Response to Cannabidiol in Induced Acute Nociceptive Pain, Allodynia and Hyperalgesia By Using a Model Mimicking Acute Pain in Healthy Adults

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

September 16, 2019

Primary Completion Date

December 23, 2019

Study Completion Date

December 23, 2019

Conditions
Pain SensationHyperalgesiaAllodynia
Interventions
DRUG

CBD 800 mg p.o

cannabidiol solution 100 mg/ml 8 ml in single-dose containers for per os administration. After a washout period of at least two weeks, the treatment group will be receiving a single-dose of the placebo solution 8 ml as a second intervention.

DRUG

Placebo p.o

single dose of oral placebo solution 8 ml matched to the IMP. After a washout period of at least two weeks, the control intervention group will be receiving the cannabidiol solution 100 mg/ml 8 ml as a second intervention.

Trial Locations (1)

4031

Department of Anaesthesiology, University Hospital of Basel (USB), Basel

All Listed Sponsors
lead

University Hospital, Basel, Switzerland

OTHER

NCT03985995 - Pain Response to Cannabidiol in Induced Acute Nociceptive Pain, Allodynia and Hyperalgesia By Using a Model Mimicking Acute Pain in Healthy Adults | Biotech Hunter | Biotech Hunter